Biopharmaceutical company Sitryx has expanded at The Oxford Science Park (TOSP).
The firm, previously in the Sherrington Building, has taken 5,500 sq ft of purpose-built laboratory and office space in the Bellhouse Building where it is only the second occupier.
The firm has grown rapidly since it collaborated with Eli Lilly in 2020 in a licensing and research arrangement. Sitryx now employs 23 staff, 16 of them research scientists.
Rory Maw, bursar of Magdalen College and director of TOSP, said: “Fast growing and innovative life sciences companies like Sitryx are core to The Oxford Science Park, and we are delighted to see it expand to the Bellhouse Building.
“It’s always exciting to see companies develop on site and we look forward to supporting Sitryx through its next phase of growth.”
Dr Neil Weir, chief executive of Sitryx, said: “This is an exciting time for us as we scale-up into excellent new premises in the Bellhouse Building, which will house teams working on multiple Lilly and Sitryx projects.”
© Thames Tap (powered by ukpropertyforums.com).
Sign up to receive your free weekly Thames Tap newsletter here.
